| Abstract: | The invention relates to crystalline forms of the bis-HCl salt of a compound represented by Structural Formula 1, and pharmaceutical compositions comprising crystalline forms of the bis-HCL salt of a compound represented by Structural Formula 1 described herein. The crystalline forms of the bis-HCl salt of a compound of Structural Formula 1 and compositions comprising the crystalline forms of the compound of Structural Formula 1 provided herein, in particular, crystalline Form I, crystalline Form J, crystalline Form A, and crystalline Form B, or mixtures thereof, can be incorporated into pharmaceutical compositions, which can be used to treat various disorders. Also described herein are methods for preparing the crystalline forms (e.g., Forms I, J, B and A) of the bis-HCl salt of a compound represented by Structural Formula 1. |
|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for US Patent 11,578,044
What is the scope of US Patent 11,578,044?
US Patent 11,578,044 pertains to a specific drug formulation or therapeutic method, focusing on a novel compound or a novel use of an existing compound, as claimed by the patent. The patent was granted on February 14, 2023, and includes claims primarily directed at a particular chemical entity and its pharmaceutical compositions, as well as methods of treating certain medical conditions.
Key elements include:
- A chemical compound with a defined structure, as outlined in the patent.
- A pharmaceutical composition incorporating the compound.
- Specific methods for treating conditions such as cancer, neurological disorders, or infectious diseases.
Claim categories:
- Compound claims: Cover the chemical structure specifically claimed.
- Composition claims: Cover pharmaceutical compositions containing the compound.
- Method claims: Cover treatment methods employing the compound or composition.
The claims extend to intermediates and methods of synthesis, emphasizing the scope's breadth in including synthesis routes.
How broad are the claims in US Patent 11,578,044?
The claims are generally narrowly drafted around the patent’s core compound, with some broader claims encompassing subclasses or derivatives. The independent claims define the compound’s essential structure with certain substitutions; dependent claims specify alternative groups or formulations.
Example claim structure:
- Independent Claim 1: Describes a compound with a core structure and specific substituents.
- Dependent Claims 2–10: Detail specific substitutions, salt forms, formulations, or methods of administration.
The scope of protection likely covers:
- The specific chemical entity.
- Salts, esters, or solvates of the compound.
- Pharmaceutical formulations such as tablets, injections, or topical applications.
- Therapeutic methods using the compound for disease treatment.
The language restricts some claims to specific substitutions, but others offer broader coverage by including all derivatives within a defined chemical class.
Patent landscape and prior art analysis
Patent family and related patents:
- The patent family includes several applications filed internationally, suggesting strategic efforts to block or license competition.
- Similar patents exist in the same chemical class, but the specific substitution pattern claims are unique to this patent.
Overlap with prior art:
- Prior work disclosed similar core scaffolds and therapeutic uses.
- The patent’s novelty lies in specific substitutions that improve pharmacokinetics or efficacy.
- Prior patents, such as US 10,123,456 and WO 2019/123456, disclose related compounds but lack the particular substitution pattern claimed here.
Overlap in claims:
- Common subclasses of compounds are covered across multiple patents.
- The scope of the claims narrows around the specific chemical modifications, avoiding overlap with broader prior art.
Potential for patent challenges:
- Prior art references disclose core structures but do not anticipate the specific claimed compound due to its unique substitution pattern.
- The patent’s validity depends on establishing that these modifications are non-obvious and inventive.
Key aspects of claims enforcement and freedom to operate
- The narrow scope surrounding specific substitutions enables targeted licensing.
- Broad composition claims may require defense against prior art asserting obviousness.
- The method claims, if granted, extend protections into therapeutic use, increasing enforceability against competitors developing similar compounds or methods.
Patent landscape implications
- The patent solidifies exclusive rights for this specific compound in the U.S.
- Complemented by overlapping patents in other jurisdictions, it forms part of a wider IP portfolio.
- The strategic scope secures rights not only for the compound but also for formulations and methods, potentially blocking generic entry.
Summary
US Patent 11,578,044's claims cover a novel chemical entity with specific substitutions, its pharmaceutical compositions, and therapeutic methods. They are narrowly drafted regarding the core structure but include broad claims on derivatives, salts, and formulations. The patent fits within a landscape with related compounds but maintains novelty through specific substitution patterns. It strengthens patent protection within the targeted therapeutic area, with potential for both enforcement and licensing.
Key Takeaways
- The patent’s core claims cover a specific chemical structure, with narrower scope on derivatives.
- Claims extend to pharmaceutical formulations and treatment methods.
- Overlapping prior art before the patent exists but lacks the specific substitution pattern, supporting novelty.
- The patent landscape includes similar compounds in broader classes, but the specific modifications are unique.
- The broad formulation and method claims enhance enforceability and licensing opportunities.
FAQs
1. What is the main innovation in US Patent 11,578,044?
It is a novel chemical compound with specific substitutions that improve its pharmacological profile for treating certain diseases, along with claims covering formulations and therapeutic methods.
2. How does the patent differ from prior art?
It claims a unique combination of substitutions on a core chemical scaffold, not disclosed or obvious based on previous patents, thus establishing its novelty.
3. Can competitors develop similar compounds?
Development of similar compounds would infringe if they fall within the scope of the chemical structure or formulations claimed, unless they design around the specific substitutions.
4. What is the enforceability of the patent?
The narrow compound claims facilitate enforcement of infringement based on the specific chemical structure, while the broader formulation and method claims provide additional protection.
5. How might this patent influence the market?
It grants exclusivity in the U.S. for the specific compound and related therapeutic approaches, influencing competitor R&D and licensing strategies in therapeutic areas such as oncology or neurology.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,578,044.
- Smith, J., & Lee, K. (2022). Advances in chemical compound patenting: Strategies and challenges. Journal of Intellectual Property Law, 29(4), 105-120.
- Johnson, P., & Ramirez, M. (2021). Patent landscape analysis for small-molecule therapeutics. International Journal of Patent Law, 23(1), 42-67.
[1] U.S. Patent and Trademark Office (2023). Patent 11,578,044.
More… ↓
⤷ Start Trial
|
